0000899243-19-029358.txt : 20191216
0000899243-19-029358.hdr.sgml : 20191216
20191216210755
ACCESSION NUMBER: 0000899243-19-029358
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191212
FILED AS OF DATE: 20191216
DATE AS OF CHANGE: 20191216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHELLER RICHARD H
CENTRAL INDEX KEY: 0001214133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 191288461
MAIL ADDRESS:
STREET 1: C/O GENENTECH INC
STREET 2: 1 DNA WAY MS 49
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080-4990
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-12
0
0001743881
BridgeBio Pharma, Inc.
BBIO
0001214133
SCHELLER RICHARD H
C/O BRIDGEBIO PHARMA, INC.
421 KIPLING STREET
PALO ALTO
CA
94301
1
1
0
0
See Remarks
Stock Option (right to buy)
37.45
2019-12-12
4
A
0
82878
0.00
A
2029-12-11
Common Stock
82878
82878
D
The stock option vests and becomes exercisable in three annual installments after December 12, 2019, subject to the Reporting Person's continued service to the Issuer through each such date.
Chairman of Research and Development
/s/ Brian Stephenson, as Attorney-in-Fact
2019-12-16